Pharma’s newest obsession involves mimicking the system that keeps people awake
Catch up on global daily news
Compelling long reads
Tune into captivating conversations
Watch engaging short films
Behind the scenes at The Economist
Possibly. But only under medical supervision
New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective and…
Performance-enhancing peptides are increasingly popular among fitness enthusiasts and biohackers, despite limited human testing…
To recover its lead in obesity drugs, the Danish giant is transforming itself
The pancreatic-cancer drug could be the first of an entirely new class of treatments
The expiry of patents in China, India and elsewhere will boost uptake dramatically
